Qube Research & Technologies (QRT)’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
Qube Research & Technologies (QRT)'s NEO Position: Q2 2026 in Review
Qube Research & Technologies (QRT) sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 65,571 shares — an estimated $487K sold.
Qube Research & Technologies (QRT) first reported a position in NEO in Q4 2019 and held it in 12 quarters. The position peaked at $1.73M in Q3 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Qube Research & Technologies (QRT) reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 65,571 NeoGenomics shares in Q2 2026, an estimated $487K.
- Qube Research & Technologies (QRT) first reported a position in NeoGenomics in Q4 2019 and held it in 12 quarters.
- Qube Research & Technologies (QRT)'s NeoGenomics position peaked at $1.73M in Q3 2023.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.